Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.zenlabsethica.com | |
Market Cap | 41.40 Cr. | |
Enterprise Value(EV) | 42.70 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 1.39 | Trailing Twelve Months Ending 2022-12 |
Price-Earning Ratio (PE) | 45.59 | Trailing Twelve Months Ending 2022-12 |
Industry PE | 35.83 | Trailing Twelve Months Ending 2022-12 |
Book Value / Share | 15.52 | Trailing Twelve Months Ending 2022-12 |
Price to Book Value | 4.10 | Calculated using Price: 63.59 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 0.65 Cr. | 6,510,015 Shares |
FaceValue | 10 | |
Company Profile | ||
Zenlabs Ethica is one of the leading marketing companies and in collaboration with Zenlabs Pharmaceutical Inc, Canada, the company develops and markets a wide range of quality, affordable and branded drugs. |
1 Day |
|
-9.86% |
1 Week |
|
-10.06% |
1 Month |
|
+2.20% |
3 Month |
|
+20.15% |
6 Month |
|
-15.41% |
1 Year |
|
+114.38% |
2 Year |
|
+157.08% |
5 Year |
|
+34.68% |
10 Year |
|
+819.24% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | -2.72 | -3.31 | 5.04 | 17.99 | 18.18 | 16.53 | -11.05 | 9.61 | 9.17 | |
Return on Capital Employed (%) | -2.72 | -3.00 | 2.90 | 21.03 | 23.85 | 23.44 | -11.27 | 13.77 | 16.59 | |
Return on Assets (%) | -1.47 | -1.76 | 1.00 | 2.99 | 3.69 | 3.91 | -2.53 | 2.35 | 2.37 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 2 | 2 | 5 | 6 | 7 | 8 | 7 | 9 | 9 | 10 | |
Non Curr. Liab. | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 2 | 2 | 4 | |
Curr. Liab. | 2 | 2 | 25 | 27 | 22 | 26 | 26 | 21 | 26 | 28 | |
Minority Int. | |||||||||||
Equity & Liab. | 4 | 4 | 30 | 33 | 30 | 35 | 34 | 32 | 38 | 42 | |
Non Curr. Assets | 0 | 3 | 3 | 3 | 2 | 2 | 2 | 4 | 4 | 6 | |
Curr. Assets | 4 | 1 | 27 | 31 | 28 | 33 | 32 | 27 | 33 | 36 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 4 | 4 | 30 | 33 | 30 | 35 | 34 | 32 | 38 | 42 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
Net Sales | 16 | 81 | 72 | 67 | 60 | 57 | 69 | 67 | |||
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
Total Income | 16 | 81 | 72 | 67 | 60 | 57 | 69 | 67 | |||
Total Expenditure | 0 | 0 | -16 | -80 | -70 | -65 | -61 | -55 | -67 | -64 | |
PBIDT | 0 | 0 | 0 | 2 | 2 | 2 | -1 | 2 | 3 | 3 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | -1 | -1 | |
Taxation | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | ||
Exceptional Items | 0 | ||||||||||
PAT | 0 | 0 | 0 | 1 | 1 | 1 | -1 | 1 | 1 | 1 | |
Adjusted EPS | 0 | 0 | 0 | 1 | 2 | 2 | -1 | 1 | 1 | 1 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | 1 | -1 | 0 | 1 | 0 | -8 | 0 | ||
Cash Fr. Inv. | -2 | 0 | 0 | 0 | 0 | 0 | |||||
Cash Fr. Finan. | 3 | 0 | 0 | 0 | 0 | -1 | 0 | ||||
Net Change | 0 | 0 | 2 | -1 | 0 | 0 | 0 | -9 | 0 | ||
Cash & Cash Eqvt | 0 | 0 | 2 | 1 | 1 | 2 | 2 | 2 | 2 |
Mon, 13 Feb 2023
Announcement Under Regulation 30(5) Of SEBI(LODR) Regulations 2015 Disclosure under Regulation 30 of SEBI (Listing Obligations andDisclosure Requirements) Regulations 2015. |
Mon, 13 Feb 2023
Announcement Under Regulation 30(5) Of SEBI(LODR) Regulations 2015 Disclosure under Regulation 30 of SEBI (Listing Obligations andDisclosure Requirements) Regulations 2015. |
Sat, 11 Feb 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication Newspaper Publication |
Fri, 24 Mar 2023 |
|
|
|
|
|